Drug Type Small molecule drug |
Synonyms Q 009, Q009 |
Target |
Mechanism OGT inhibitors(O-linked N-acetylglucosamine (GlcNAc) transferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | AU | 28 Aug 2023 | |
Prostatic Cancer | Preclinical | AU | 28 Aug 2023 |